02 April 2024: Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in Type 2 Diabetes
Bo Lou ABCDE* , Yu-Lan Hu BCF , Zhong-Hua Jiang CDDOI: 10.12659/MSM.942509
Med Sci Monit 2024; 30:e942509
Table 2 Univariate logistic analysis for the development of diabetic peripheral neuropathy.
| Indicators | B | SB | Wald χ2 | p | OR (95% CI) |
|---|---|---|---|---|---|
| TC (mmol/L) | −0.13 | 0.35 | −0.36 | 0.72 | 0.88 (0.44–1.76) |
| TG (mmol/L) | −0.14 | 0.23 | −0.60 | 0.55 | 0.87 (0.55–1.37) |
| LDL-C (mmol/L) | −0.06 | 0.28 | −0.22 | 0.83 | 0.94 (0.54–1.63) |
| HDL-C (mmol/L) | −1.30 | 0.64 | −2.02 | 0.04 | 0.27 (0.07–0.94) |
| HbA1c (%) | 0.65 | 0.19 | 3.41 | 1.92 (1.35–2.88) | |
| Fins (μIU/ml) | −0.18 | 0.12 | −1.52 | 0.13 | 0.84 (0.66–1.05) |
| FBG (mmol/L) | 0.19 | 0.12 | 1.54 | 0.12 | 1.21 (0.96–1.57) |
| 24 h UAER (mg/24 h) | 0.02 | 0.04 | 0.47 | 0.64 | 1.02 (0.95–1.09) |
| Cys-C (mg/L) | 1.03 | 0.94 | 1.10 | 0.27 | 2.82 (0.58–24.17) |
| HOMA-IR | −0.03 | 0.22 | −0.16 | 0.87 | 0.97 (0.62–1.49) |
| HOMA-β | −0.04 | 0.02 | −2.01 | 0.05 | 0.96 (0.92–0.99) |
| NLR | 1.84 | 0.73 | 2.52 | 0.01 | 6.30 (1.67–29.43) |